[HTML][HTML] Osteopontin in cardiovascular diseases
K Shirakawa, M Sano - Biomolecules, 2021 - mdpi.com
Unprecedented advances in secondary prevention have greatly improved the prognosis of
cardiovascular diseases (CVDs); however, CVDs remain a leading cause of death globally …
cardiovascular diseases (CVDs); however, CVDs remain a leading cause of death globally …
[HTML][HTML] Osteopontin in Cardiovascular Diseases
K Shirakawa, M Sano - Biomolecules, 2021 - ncbi.nlm.nih.gov
Unprecedented advances in secondary prevention have greatly improved the prognosis of
cardiovascular diseases (CVDs); however, CVDs remain a leading cause of death globally …
cardiovascular diseases (CVDs); however, CVDs remain a leading cause of death globally …
Osteopontin in Cardiovascular Diseases
K Shirakawa, M Sano - 2021 - agris.fao.org
Unprecedented advances in secondary prevention have greatly improved the prognosis of
cardiovascular diseases (CVDs); however, CVDs remain a leading cause of death globally …
cardiovascular diseases (CVDs); however, CVDs remain a leading cause of death globally …
Osteopontin in Cardiovascular Diseases.
K Shirakawa, M Sano - Biomolecules, 2021 - europepmc.org
Unprecedented advances in secondary prevention have greatly improved the prognosis of
cardiovascular diseases (CVDs); however, CVDs remain a leading cause of death globally …
cardiovascular diseases (CVDs); however, CVDs remain a leading cause of death globally …
[PDF][PDF] Osteopontin in Cardiovascular Diseases. Biomolecules 2021, 11, 1047
K Shirakawa, M Sano - 2021 - pdfs.semanticscholar.org
Unprecedented advances in secondary prevention have greatly improved the prognosis of
cardiovascular diseases (CVDs); however, CVDs remain a leading cause of death globally …
cardiovascular diseases (CVDs); however, CVDs remain a leading cause of death globally …
Osteopontin in Cardiovascular Diseases
K Shirakawa, M Sano - Biomolecules, 2021 - pubmed.ncbi.nlm.nih.gov
Unprecedented advances in secondary prevention have greatly improved the prognosis of
cardiovascular diseases (CVDs); however, CVDs remain a leading cause of death globally …
cardiovascular diseases (CVDs); however, CVDs remain a leading cause of death globally …
Osteopontin in Cardiovascular Diseases.
K Shirakawa, M Sano - Biomolecules (2218-273X), 2021 - search.ebscohost.com
Unprecedented advances in secondary prevention have greatly improved the prognosis of
cardiovascular diseases (CVDs); however, CVDs remain a leading cause of death globally …
cardiovascular diseases (CVDs); however, CVDs remain a leading cause of death globally …
Osteopontin in Cardiovascular Diseases
K Shirakawa, M Sano - Biomolecules, 2021 - cir.nii.ac.jp
抄録< jats: p> Unprecedented advances in secondary prevention have greatly improved the
prognosis of cardiovascular diseases (CVDs); however, CVDs remain a leading cause of …
prognosis of cardiovascular diseases (CVDs); however, CVDs remain a leading cause of …
Osteopontin in cardiovascular diseases
K Shirakawa, M Sano - Biomolecules, 2021 - keio.elsevierpure.com
抄録 Unprecedented advances in secondary prevention have greatly improved the
prognosis of cardiovascular diseases (CVDs); however, CVDs remain a leading cause of …
prognosis of cardiovascular diseases (CVDs); however, CVDs remain a leading cause of …
Osteopontin in Cardiovascular Diseases
K Shirakawa, M Sano - Biomolecules, 2021 - search.proquest.com
Unprecedented advances in secondary prevention have greatly improved the prognosis of
cardiovascular diseases (CVDs); however, CVDs remain a leading cause of death globally …
cardiovascular diseases (CVDs); however, CVDs remain a leading cause of death globally …